Jefferies Starts Atara Biotherapeutics (ATRA) at Buy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. LITE
4. AAPL
5. ABBV
6. MRVL
7. CL
8. LYB
9. TFII
10. RXRX

Go back to Jefferies Starts Atara Biotherapeutics (ATRA) at Buy

Atara Biotherapeutics (ATRA) Reports Q3 Loss of $4.20

November 12, 2014 6:36 AM EST

Atara Biotherapeutics (NASDAQ: ATRA) reported Q3 EPS of ($4.20), versus ($2.59) reported last year.

For earnings history and earnings-related data on Atara Biotherapeutics (ATRA) click here.

... More

Goldman Sachs Starts Atara Biotherapeutics (ATRA) at Neutral

November 10, 2014 7:20 AM EST

Goldman Sachs initiated coverage on Atara Biotherapeutics (NASDAQ: ATRA) with a Neutral rating and a price target of $30.00.

Analyst Navdeep Singh said, "Atara is an early-stage biotech developing (1) PINTA 745 for kidney dialysis patients who suffer from muscle wasting and (2) STM 434 for advanced ovarian... More